The oxidative neurotoxicity of clioquinol
- 29 June 2005
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 49 (5) , 687-694
- https://doi.org/10.1016/j.neuropharm.2005.04.023
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolismProceedings of the National Academy of Sciences, 2004
- Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In VivoNeuron, 2003
- Design of therapeutic chelating agentsBiochemical Society Transactions, 2002
- Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation productsJournal of Neurosurgery, 2002
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MicePublished by Elsevier ,2001
- Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal DepletionJournal of Biological Chemistry, 1999
- Zinc Metabolism in the Brain: Relevance to Human Neurodegenerative DisordersNeurobiology of Disease, 1997
- Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitroNeuroscience, 1995
- Iron and oxygen radicals in brainAnnals of Neurology, 1992
- Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assayJournal of Neuroscience Methods, 1987